Inflammatory dilated cardiomyopathy (DCMi) is among the most common causes of noncon genital heart failure in individuals under the age of 40 (Dimas et al., 2009 ). There has been only limited success with symptomatic therapy in chronic DCMi patients, leaving cardiac tran splantation the only cure for end stage heart failure secondary to DCMi (Pietra et al., 2012) . Autoimmunity to heart tissue is often involved in the pathogenesis of DCMi (Čiháková and Rose, 2008; Cooper, 2009) . In an effort to in vestigate the immunopathologic mechanism responsible for DCMi in humans, we have adopted a mouse model of experimental autoim mune myocarditis (EAM). EAM is induced by immunization of genetically susceptible BALB/c mice with a peptide derived from the cardiac myosin heavy chain  (MyHC 614629 ). Immu nized mice develop myocarditis characterized by inflammatory infiltration peaking about day 21, and subsequently progress to DCMi around day 40 to day 70, characterized by cardiac fibro sis and impairment of cardiac function (Čiháková et al., 2004) .
EAM is a CD4 + T helper cell-dependent disease Allen, 1991, 1993) . One of the CD4 + T helper cell subsets, Th17 cells, has been observed to infiltrate the heart during EAM (Baldeviano et al., 2010) , and has been reported to be critical in autoimmunity (Korn et al., 2009) . Furthermore, patients with DCMi have increased numbers of Th17 cells in their blood and an elevated level of Th17 cytokines in serum, suggesting that Th17 cells are involved in the pathogenesis of DCMi (Ding et al., 2010; Yuan et al., 2010) . When we examined whether the hallmark Th17 cytokine, IL17A, drives the pathogenesis of myocarditis, we discovered that Il17a / mice were completely protected from the development of DCMi, although they had myocardial inflammation comparable in over all severity to WT controls (Baldeviano et al., 2010) . Thus, IL17A is dispensable for early IL17A-dependent DCMi, we describe a novel immunologi cal pathway connecting IL17A with MO/Ms that drives DCMi development.
RESULTS

IL-17A/IL-17RA signaling is required for the development of DCMi
We previously demonstrated that Il17a / mice are suscepti ble to EAM but are protected from DCMi (Baldeviano et al., 2010) . To investigate the downstream functions of IL17A in the development of DCMi, we first excluded the possibility that other IL17 family cytokines signaling though the IL17 receptor contributed to the DCMi phenotype by comparing disease in Il17ra / and Il17a / mice. Similar to Il17a / mice, Il17ra / mice were fully protected from DCMi after immunization with myocarditogenic peptide MyHC 614629 , although they developed myocarditis histologically compara ble to WT controls ( Fig. 1 A) . Il17ra / mice retained normal heart function and were protected from ventricular dilation (Fig. 1, B and C) . In addition, Il17ra / mice developed limited cardiac enlargement (Fig. 1 D) and fibrosis, whereas WT mice hearts had significant fibrosis as determined by hydroxyproline stage myocarditis but required for the progression to DCMi. These results indicated a critical role of IL17A in driving cardiac damage and fibrosis during the development of DCMi. Similar profibrotic functions of IL17A have been reported in cirrhosis (Lan et al., 2009 ) and fibrotic lung injury (Wilson et al., 2010) models.
Monocytes (MOs) and macrophages (Ms) are key effector cells during inflammatory processes (Gordon and Taylor, 2005) including myocarditis and DCMi. MO/Ms comprise about half of all heartinfiltrating inflammatory cells at the peak of EAM and play important roles in the pathogenesis Barin et al., 2012) . Monocytes arise from hematopoietic stem cells and form dis tinct subpopulations. In mouse, the two monocyte subsets, CCR2 hi CX3CR1 lo Ly6C hi and CCR2 lo CX3CR1 hi Ly6C lo monocytes, infiltrate sites of inflammation responding to dif ferent chemokine signals and differentiate into inflammatory Ms guided by local cytokine signals (Gordon and Taylor, 2005; Shi and Pamer, 2011) . The balance between MO/M subsets and their differentiation is critical in determining the pathogenic outcome in immune responses (Wynn et al., 2013) . In this paper, while examining the pathogenic mechanisms of Data were analyzed by one-way ANOVA followed by Tukey's post-test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001.
to the heart, as the levels of Ly6C hi and Ly6C lo monocytes in the spleen were comparable between WT and Il17ra / mice (Fig. 2, G and H) . This was dissimilar to the reduction in cardiac infiltration of Ly6G hi neutrophils, which was also de tected in the spleen (Fig. 2 I) . The specificity of the difference in the ratio of Ly6C hi to Ly6C lo MO/Ms in the heart indi cates that local but not systemic signals drive this change. In summary, protection from DCMi in Il17ra / mice is closely associated with the composition of myeloid populations in the heart, particularly with a significant diminution of neu trophils and Ly6C hi MO/Ms. Intracardiac Ly6C hi MO/Ms have proinflammatory and profibrotic phenotype, whereas Ly6C lo MO/Ms up-regulate insulin-like growth factor 1 (IGF-1) and MMP production The striking decrease in the ratio of Ly6C hi to Ly6C lo MO/Ms in the absence of IL17RA signaling led us to examine the contribution of these cell subsets to cardiac damage and fibro sis during DCMi development. Using FACS, we isolated CD45 + Ly6G  CD11b + Ly6C hi and CD45 + Ly6G  CD11b + Ly6C lo MO/Ms separately from WT mouse hearts at the peak of inflammation on day 21. Transcriptome profiles were generated by realtime quantitative PCR (qPCR) analysis of these two populations ( Fig. 3 A and Table 1) . assay ( Fig. 1 E) and Masson's trichrome staining (Fig. 1 , F and G). Thus, we established that the IL17A/IL17RA signaling pathway is required for the development of DCMi. Moreover, because Il17ra / mice had disease similar to Il17a / mice, it is unlikely that other cytokines of the IL17 family are critical in the pathogenesis of DCMi.
IL-17RA deficiency alters the composition of heart-infiltrating myeloid populations during EAM Histopathologic and flow cytometric analyses (Fig. 2 A) revealed that Il17ra / mice had a similar degree of inflamma tion and quantitatively comparable numbers of heartinfiltrating CD45 + cells as WT controls (Fig. 2 B) . There was no signi ficant difference in the percentages of infiltrating CD4 + T cells or SiglecF + eosinophils (unpublished data). However, IL17RA deficiency led to profound changes in the compo sition of infiltrating myeloid cells. Specifically, Il17ra / mice had significantly diminished Ly6G hi neutrophil infiltration in their hearts (Fig. 2 C) . Moreover, even though the proportion of total Ly6G  CD11b + monocyte/macrophage (MO/M) population in CD45 + cells was comparable (Fig. 2 D) , Il17ra / mice had significantly lower levels of Ly6C hi population and higher levels of Ly6C lo population within the Ly6G  CD11b + MO/M compartment (Fig. 2, E and F) . Importantly, this shift in MO/M populations was restricted To summarize, heartinfiltrating Ly6C hi MO/Ms dis play a proinflammatory and profibrotic phenotype indicat ing a pathogenic role, whereas Ly6C lo MO/Ms produced a high level of MMPs and IGF1 suggesting a protective role. Therefore, Il17ra / mice had significantly less inflam matory monocytic infiltration in their hearts during the peak of inflammation, which helps to explain their resistance to DCMi.
Ly6C hi MO/Ms aggravate DCMi
To test the hypothesis that Ly6C hi MO/Ms directly promote DCMi, we manipulated the balance of Ly6C hi and Ly6C lo MO/Ms in vivo using two previously published methods. First, we injected mice with clodronateloaded liposomes, which have been shown to induce apoptosis in MO/Ms (van Rooijen et al., 1996) . Second, we injected mice with PBSloaded liposomes, which have been reported to induce a phenotypic switch from Ly6C hi to Ly6C lo MO/Ms through the phagocytosis of the liposomes (Ramachandran et al., 2012 ).
Ly6C hi MO/Ms were characterized by higher Ccr2 ex pression. Compared with the Ly6C lo population, Ly6C hi MO/Ms produced higher levels of several proinflammatory cytokines and enzymes (Il1b, Il6, Il12a, Tnf, and Nos2) . In ad dition, Ly6C hi MO/Ms upregulated thrombospondin1 (Thbs1), which activates latent TGF trapped in the extra cellular matrix (ECM) and initiates TGF-dependent fibrosis pathways (Frangogiannis, 2012) . Ly6C hi MO/Ms also pro duced more arginase 2 (Arg2) and YM1 (Chi3l3), which are traditionally associated with M2 tissue repair macrophages, in dicating that the classic M1/M2 dichotomy does not perfectly fit with Ly6C hi /Ly6C lo MO/M phenotypes in the cardiac inflammation scenario during EAM and DCMi. Conversely, Ly6C lo MO/Ms are characterized by greater expression of Cx3cr1, and they produced higher levels of matrix metallopro teinases (Mmp9 and Mmp12) and Igf1 (Fig. 3 A) . These mole cules have been implicated in protecting against tissue fibrosis by breaking down excessive ECM (Ramachandran et al., 2012) as well as by other mechanisms (Bessich et al., 2013) . (clodronate) . 63 d after immunization, mice underwent echocardiography and were sacrificed. Data are representative of 2 independent experiments. (F) Ejection fraction (%) by echocardiography. Dash line marks 60%, the threshold for severe DCMi. (G) Heart weight/body weight ratio (‰). (H) Cardiac hydroxyproline assay normalized to heart weight. For bar graphs, data points represent individual mice. Horizontal bars represent mean. Data were analyzed by one-way ANOVA followed by Tukey's post-test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; n.s. = not significant. not essential in the pathogenesis of acute myocarditis, they play critical roles in cardiac fibrosis and the development of DCMi.
IL-17A/IL-17RA signaling to cardiac-resident cells is required for the development of DCMi
Protection of Il17ra / mice against DCMi is associated with significant diminution in neutrophil and Ly6C hi monocyte infiltration. In the inflamed heart, IL17A receptors are ex pressed by both infiltrating hematopoietic cells (Gaffen, 2009) and cardiacresident cells (Fig. 4 A) . To determine whether IL17A drives DCMi by directly signaling to infiltrating hematopoietic cells or indirectly through cardiacresident cells, we generated BM chimeras. WT or Il17ra / BMs were transferred into lethally irradiated Il17ra / or WT recipi ents to generate BM chimeras with IL17RA signaling ablated in either hematopoietic or nonhematopoietic compartments (Fig. 4 B) . Syngeneic transfers were performed as controls to exclude the effects of the BM reconstruction itself. Chimeras lacking IL17RA on their cardiacresident cells were pro tected from DCMi, regardless of the genotype of their BM donors. Their hearts retained normal function (Fig. 4 C) with lower levels of collagen deposition in their hearts (Fig. 4 D) . Twoway ANOVA (genotype of recipients vs. genotype of donors) confirmed the genotype of recipient mice as the primary source of variance. Chimeras lacking IL17RA sig naling in their hematopoietic compartment showed partially mitigated DCMi compared with WT syngeneic transfer con trols; however, they were not fully protected from DCMi as the chimeras with Il17ra / BMs (Fig. 4 , C and D), suggesting
To assess how these treatments affect the myocarditis phase of EAM, we injected PBSloaded or clodronateloaded lipo somes on days 14, 16, 18, and 20 of EAM, and sacrificed the mice on day 21. PBSloaded liposomes significantly reduced the proportion of Ly6C hi MO/Ms among all Ly6G  CD11b + MO/Ms (Fig. 3 B) and dramatically lowered the ratio of Ly6C hi to Ly6C lo MO/Ms (Fig. 3 C) , while not affecting the total number of Ly6G  CD11b + MO/Ms among heart infiltrating CD45 + cells (Fig. 3 D) . Clodronateloaded lipo somes, however, significantly decreased the total number of Ly6G  CD11b + MO/Ms in the heart (Fig. 3 D) , but also disproportionately reduced the proportion of Ly6C hi MO/Ms among MO/Ms (Fig. 3 B) and lowered the Ly6C hi to Ly6C lo MO/M ratio (Fig. 3 C) . Both PBSloaded and clodronateloaded liposome treatments had no signifi cant effect on the severity of EAM on day 21 (not depicted), and the levels of Ly6G hi neutrophil infiltration in the heart were not affected (Fig. 3 E) .
We next administered PBS or clodronateloaded lipo somes intravenously every other day from days 14 to 35 of EAM, through the peak of cardiac inflammation, and as sessed the severity of DCMi at day 63. Clodronateloaded liposomes protected mice from the deterioration of cardiac function (Fig. 3 F) . PBSloaded liposomes also showed promising effects, as none of the PBSloaded liposome treated mice developed severe DCMi defined by an ejection fraction <60% (Fig. 3 F) . Furthermore, mice treated with PBSloaded or clodronateloaded liposomes had significantly reduced cardiac enlargement (Fig. 3 G) and fibrosis (Fig. 3 H) . These results illustrate that although Ly6C hi MO/Ms are CFs from naive WT mice were cultured with 100 ng/ml rIL-17A, 5 ng/ml rTNF, or two cytokines combined for 24 h. Supernatants were collected after culture, and the levels of CXCL1, CCL2, GM-CSF, G-CSF, IL-6, and LIF were measured by ELISA. (D-F) CFs from naive WT mice were cultured with 100 ng/ml rIL-17A, 5 ng/ml rTNF, or two cytokines combined for 6 h. RNA were isolated from CFs and the mRNA levels of Cxcl1, Ccl2, Csf2, Csf3, Il6, and Lif (D) , Col1a1 and Col3a1 (E), and Cx3cl1 (F) were determined by real-time qPCR and normalized to housekeeping gene Hprt. (C-F) Data are representative of 3 independent experiments. Data are shown as mean + SEM of 3 replicates and analyzed by one-way ANOVA followed by Tukey's post-test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; n.s. = not significant.
effect contributed to CM death during myocardial infarction in adults (Liao et al., 2012) . However, adult CMs stimulated with rIL17A retained their viability and morphology when compared with unstimulated CM culture (Fig. 5, A and B) . Thus, IL17A does not induce apoptosis in primary adult CMs in vitro. In addition, qPCR assay of CM mRNA did not detect any induction of classic IL17A targets, including Il6 and Cxcl1 (unpublished data). Previous studies suggested that TNF synergizes with IL17A by stabilizing mRNA of IL17A targets (Ruddy et al., 2004) . However, addition of rTNF to the culture did not induce activation of IL17A targets either (unpublished data). IL17A signals through the classical NFB pathway, which requires the degradation of NFB inhibitor IB (Gaffen, 2009 ). However, Western blotting showed that IL17A failed to induce IB degra dation in adult CMs (Fig. 5 C) . To summarize, IL17A does not appear to have any significant effects on adult CMs in vitro, indicating that CMs are not the primary IL17A target during DCMi.
IL-17A induces myeloid chemokines and cytokines production from cardiac fibroblasts (CFs) Next, we assessed the effect of IL17A signaling to CFs. We isolated primary CFs from WT adult mice and tested the purity of CF culture to rule out the possibility of contamination by macrophages and other cells. BMderived macrophages (BMDMs) were used as a positive control. First, using immuno fluorescence microscopy, we found that cells in our CF culture expressed  smooth muscle actin (SMA) but not myeloid marker CD11b (Fig. 6 A) . Second, by flow cytometry, we did not detect any CD45 + leukocytes in our culture contaminating the CD44 + CF population (Fig. 6 B) . Third, by qPCR, we de tected the expression of fibroblastspecific genes Agtr1a (angio tensin II receptor, type 1a) and Ddr2 (discoidin domain receptor family member 2) in CF culture, but not genes expressed by myeloid cells, including Ccr2, Cx3cr1, Mpo, or Pgcd1lg2 (PDL2; unpublished data). Based on the sensitivity of qPCR assay and the number of cells in the culture, macrophage contamination in CF culture, if any, is extremely low.
To assess the effect of IL17A on CFs, we isolated primary CFs from adult WT mice and stimulated with IL17A for 24 h. IL17A was able to induce the production of CXCL1, CCL2, GMCSF, GCSF, IL6, and leukemia inhibitory fac tor (LIF; Fig. 6 C) , but not IL1, IL33, TNF, TGF, CCL8, and CCL11 (not depicted). Addition of TNF further enhanced the stimulatory effects of IL17A (Fig. 6 C) . Interrogation of mRNA levels by qPCR confirmed these effects (Fig. 6 D) .
However, IL17A failed to directly stimulate the production of collagen (Fig. 6 E) or Cx3cl1 (Fig. 6 F) in CFs, indicating that more complex mechanisms were involved in regulating fibrosis and the accumulation of Ly6C lo MO/Ms in Il17ra / hearts during IL17A-driven DCMi.
To confirm these results in vivo, we next isolated CD45  CD34 + CD146 + CD44 hi CD31  CFs from the hearts of immu nized WT and Il17ra / mice by FACS (Fig. 7 A) . qPCR analy sis showed that CFs from Il17ra / mice expressed significantly lower levels of Cxcl1, Csf2, Csf3, and Il6 compared with CFs from WT mice (Fig. 7 B) , confirming our in vitro findings that IL17A stimulated the production of proinflammatory cyto kines and chemokines in CFs. However, the levels of Ccl2 and Lif were comparable between CFs from WT and Il17ra / mice (unpublished data), indicating that more complex pathways were involved. Endothelial cells (ECs) have also been reported to respond to IL17A signals. We therefore also isolated CD45  CD34 + CD146 + CD44 lo CD31 hi ECs by FACS from the hearts of WT mice on day 21 of EAM ( Fig. 7 A) . qPCR analysis showed that the mRNA levels of proinflammatory cytokines and chemokines of interest were dramatically higher in CFs than ECs, with the exception of Csf3 (Fig. 7 C) , indicating that, among cardiacresident cells, CFs are the dominant source of proinflammatory cytokines and chemokines upon IL17A stimulation during EAM and DCMi.
CXCL1 is a major chemokine for neutrophil chemotaxis, and the induction of CXCL1 in CFs by IL17A helps explain the differences in the composition of heartinfiltrating myeloid cells between Il17ra / and WT mice. Moreover, GMCSF, GCSF, and IL6 play important roles in the differentiation and activation of myeloid cells, suggesting further interactions of CFs and inflammatory cells under IL17A stimulation.
IL-17A is able to drive the differentiation of monocytes in trans through CFs
To determine whether IL17A is able to instruct the differ entiation of monocytes by inducing cytokine production from CFs, we designed an in vitro fibroblast-monocyte co culture system. Because spleen is the major reservoir of monocytes during cardiac inflammation (Swirski et al., 2009 ), Ly6G  CD11c  CD11b + F4/80  Ly6C hi monocytes were FACS sorted from naive Il17ra / mouse spleen and cocultured with primary adult mouse CFs. To exclude direct signaling of IL17A to monocytes, we used Il17ra / mice as monocyte donors. Il17ra / Ly6C hi monocytes were cocultured with WT CFs for 48 h with or without rIL17A stimulation. Be cause monocytes themselves produce TNF, no rTNF was added rIL17A had no additional effects (Fig. 8 D) . Thus, IL17A induced proinflammatory changes in Ly6C hi monocytes indi rectly through CFs, suggesting that CFs actively participate in immune response and serve as a mediator between IL17A and Ly6C hi monocytes.
IL-17A drives the differentiation of monocytes by inducing GM-CSF production in CFs
We have shown that IL17A induces the production of IL6, GCSF, and GMCSF from CFs (Fig. 6, C and D; and Fig. 7 B) , which are all potent drivers of myeloid cells differ entiation and activation. We therefore blocked these cyto kines with neutralizing antibodies in our CF/monocyte coculture system to determine which cytokine is the main transducer of the IL17A signals to monocytes. Anti-IL6RA mAb and anti-GCSF mAb both failed to reverse the effect of IL17A (unpublished data). However, anti-GMCSF mAb to the cultures. After 48 h of coculture, monocytes were sep arated from CFs by FACS. qPCR assay of monocytes showed that, through its effects on CFs, IL17A was able to indirectly upregulate proinflammatory genes Il1b, Il6, Il12a, and Nos2, while downregulating suppressive gene Il10 (Fig. 8 A) . We repeated the experiment with Il17ra / CFs. rIL17A failed to induce significant difference in Il17ra / monocytes (Fig. 8 B) without responding CFs, demonstrating that these effects were IL17A-specific. IL17A, however, could not induce de novo conversion of Ly6C lo MO/Ms to Ly6C hi MO/Ms either directly or indirectly through CFs. rIL17 failed to affect the Ly6C hi to Ly6C lo ratio in Ly6G  CD11c  CD11b + F4/80  monocytes isolated from the spleen of WT mice (Fig. 8 C) . Co culture of splenic Ly6G  CD11c  CD11b + F4/80  monocytes from Il17ra / mice with WT CFs resulted in lower level of Ly6C hi MO/Ms, likely due to phagocytosisinduced conver sion (Ramachandran et al., 2012) . However, addition of Cxcl1, Csf2, Csf3, Il6 , and Lif in CFs and ECs from WT mice were determined by qPCR and normalized to housekeeping gene Hprt. For bar graphs, data are representative of 2 independent experiments. Data are shown as mean + SEM of 3 replicates and analyzed by unpaired two-tailed Student's t test. *, P < 0.05; ***, P < 0.001; ****, P < 0.0001; n.s. = not significant. (A and D) , or unpaired two-tailed Student's t test (B and C). *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; n.s. = not significant. strongly suppressed the indirect effect of IL17A on Ly6C hi monocytes (Fig. 8 A) . Moreover, the phenotype of mono cytes cocultured with rGMCSF resembled monocytes from the rIL17Astimulated coculture (Fig. 8 A) . Therefore, IL17A induces GMCSF production from CFs, which mediates the proinflammatory differentiation of Ly6C hi monocytes.
Il17ra / mice have less proinflammatory Ly6C hi MO/M infiltration in vivo
We have shown that IL17A instructs proinflammatory dif ferentiation of Ly6C hi monocytes by inducing GMCSF pro duction in vitro (Fig. 8 A) . To investigate whether IL17A drives MO/Ms into a proinflammatory phenotype in the heart, we isolated Ly6C hi MO/Ms from the hearts of WT or Il17ra / mice at the peak of inflammation (day 21). Because IL17A directs proinflammatory changes in mono cytes in vitro, we expected that Ly6C hi MO/Ms from Il17ra / mice hearts would possess a less inflammatory phe notype due to lack of IL17RA signaling. qPCR assay showed that Ly6C hi MO/Ms from Il17ra / mice hearts produced lower levels of proinflammatory cytokines Il1b, Il6 (Fig. 9 A) , mirroring the phenotype observed from in vitro coculture experiments. Importantly, Ly6C hi monocytes isolated from the spleens of Il17ra / mice had expression of Il1b and Il6 comparable to WT splenic Ly6C hi monocytes (Fig. 9 B) , dem onstrating that the effects of IL17A on MO/Ms was a local phenomenon specific to the heart during EAM.
To confirm the in vitro results that GMCSF mediates these effects, we injected immunized WT mice with rGM CSF, 36 and 12 h before sacrifice on day 21 of EAM, and iso lated Ly6C hi MO/Ms from the hearts by FACS. qPCR analysis showed that Ly6C hi MO/Ms from the hearts of rGMCSF-treated mice had higher levels of Il1b and Il6 ex pression compared with controls injected with PBS (Fig. 9 C) , illustrating that GMCSF elicits proinflammatory polarization of Ly6C hi MO/Ms MO/Ms during EAM and DCMi.
Thus, we confirmed our previous in vitro results in vivo, underscoring that IL17A and GMCSF directs the polariza tion of cardiac MO/Ms and the development of DCMi after EAM. However, Ly6C hi MO/Ms from Il17ra / mice expressed comparable levels of Il12a, Nos2, and Il10 (unpub lished data), which is not consistent with the findings from in vitro coculture experiment. This difference highlights the complexity of the in vivo inflammatory environment and suggests that other pathways play a role in the programming of MO/Ms at the site of inflammation. DCMi: First, depletion of Ly6G  CD11b + MO/Ms by clodronateloaded liposomes also lowered the ratio of Ly6C hi to Ly6C lo MO/Ms in the heart. Second, PBSloaded lipo somes specifically lowered the ratio of Ly6C hi to Ly6C lo MO/ Ms without affecting the total number of MO/Ms in the heart. Neither method induced any change in severity of myocarditis, but both protected mice from cardiac fibrosis and the development of severe DCMi, demonstrating that Ly6C hi MO/Ms aggravate the development of DCMi. Similarly, in a heart ischemia/reperfusion model, early recruitment of Ly6C hi monocytes is associated with injury, preceding the re cruitment of Ly6C lo monocytes, which appear to be involved in myocardial healing (Nahrendorf et al., 2007) . Ly6C lo monocytes were shown to be able to arrest and reverse fibro sis in a model of CCl 4 induced liver damage (Ramachandran et al., 2012) .
We further suggest that the M1/M2 paradigm does not perfectly overlap with Ly6C hi and Ly6C low subsets and does not accurately describe these two different populations in the heart during EAM. Traditionally, M1 represents a population that promotes inflammation, whereas M2 is responsible for tissue repair and fibrosis (Gordon and Taylor, 2005) . However, in our EAM model, Ly6C hi MO/Ms have a proinflamma tory and profibrotic phenotype. They upregulate classic M1 markers like Tnf and Nos2, as well as M2 markers like Chi3l3, while Ly6C lo MO/Ms produced molecules that are be lieved to help resolve fibrosis (Ramachandran et al., 2012; Bessich et al., 2013) . Unlike classic tissueresident macrophage populations in the liver and lung, both Ly6C hi and Ly6C lo MO/ Ms in the heart express very dim levels of classic murine macrophage marker F4/80, and the levels are comparable be tween Ly6C hi and Ly6C lo populations; in contrast, Ly6C lo population expresses CD11c and MHC II at higher levels than Ly6C hi MO/Ms (unpublished data). However, we did not observe the discrepancy in MHC II expression within Ly6C lo population recently described by Epelman et al. (2014) ; in our EAM model, all the Ly6C lo MO/Ms in the heart express high levels of MHC II (not depicted). Recent studies showed more complex relationships between cardiac Ly6C hi and Ly6C lo MO/Ms, and suggested the conversion between the two in the heart: Hilgendorf et al. (2014) discov ered that instead of being recruited from the blood Ly6C lo pool, Ly6C lo MO/Ms derived from Ly6C hi MO/Ms in the heart; Epelman et al. (2014) demonstrated that the Ly6C lo population arises during early development, and is maintained through distinct mechanisms at steady state and during in flammation. In our EAM model, using a BrdU pulse approach, we also found that cardiac Ly6C hi MO/Ms undergo rapid turnover, whereas Ly6C lo population was more stable (un published data), confirming these findings.
We have shown previously that MO/Ms express receptors for IL17A but direct stimulation of MO/Ms with IL17A does not induce a proinflammatory phenotype (Barin et al., 2012) . BM chimeras revealed that deficiency of IL17A/ IL17RA signaling in nonhematopoietic cells is sufficient to suppress the augmentation of immune response and protect mice DISCUSSION About 9-16% of patients with myocarditis progress to dilated cardiomyopathy (Herskowitz et al., 1993; Sagar et al., 2012) , but there are no reliable biological markers that would help identify myocarditis patients with high risk of progressing to DCMi (Cooper, 2009 ). Currently, a definitive diagnosis of myocarditis depends on a biopsy of the myocardium. Based on the Dallas criteria, the heart is evaluated based on the pres ence and density of inflammatory infiltration and CM death (Aretz et al., 1987) . However, our study clearly shows that not only the quantity but also the quality of these infiltrating cells is critical in predicting the development of DCMi. Similar to Il17a / mice, Il17ra / mice developed myocarditis and had overall CD45 + cell infiltration comparable to WT, but were nonetheless not susceptible to DCMi. This protection is asso ciated with a different infiltration profile. Il17ra / mice had diminished infiltration of neutrophils, which have been im plicated in inducing cardiac damage and rupture in a myocar dial infarction model (VintenJohansen, 2004; Hiroi et al., 2013) . A recent study revealed that neutrophils also play an important role in the recruitment of monocytes (Wantha et al., 2013) . In addition, Il17ra / mice had significantly less infiltration of proinflammatory monocytes and lower Ly6C hi to Ly6C lo MO/M ratios specifically in their heart, which represents a potentially useful biomarker for DCMi risk in myocarditis patients.
Monocytes and macrophages are key effector cells in EAM (Barin et al., 2012) as well as in human giant cell myocar ditis (Cooper et al., 2007) . MO/Ms are not a homogeneous population (Hashimoto et al., 2011) . However, cardiac disease literature tended to ignore their heterogeneity until recently, leading to substantial disagreement in reported findings. Dur ing early development, progenitor cells migrate into solid or gans and develop into tissueresident macrophages, which are maintained by local proliferation with minimal replen ishment from blood monocytes (Hashimoto et al., 2013; Yona et al., 2013) . During an inflammatory process, blood mono cytes rapidly migrate to the site of inflammation, where they mature into macrophages in response to local stimulating signals (Sica and Mantovani, 2012) . In mouse, monocytes form two major subsets in blood, CCR2 hi CX3CR1 lo Ly6C hi (resembling human CD14 hi CD16  monocytes) and CCR2 lo CX3CR1 hi Ly6C lo (resembling human CD14 lo CD16 + mono cytes; Geissmann et al., 2003; Shi and Pamer, 2011) .
In our study, the balance of these two MO/Ms subsets in the heart determines the outcome of inflammation. Thus, IL17RA deficiency leads to a lower Ly6C hi /Ly6C lo ratio and protection from DCMi. We found that heartinfiltrating Ly6C hi MO/Ms had a proinflammatory and profibrotic phe notype. The proinflammatory cytokines and TGF activators they produce are likely to play critical roles in cardiac remod eling. Ly6C lo monocytes in heart produced high levels of MMPs and IGF1, which have been described as protective in fibrosis (Ramachandran et al., 2012; Bessich et al., 2013) . We used two methods to manipulate the balance of Ly6C hi and Ly6C lo MO/Ms to demonstrate the role they play in Our data now point to GMCSF acting as a key mediator of IL17A-driven autoimmunity in DCMi: IL17A signaling induces GMCSF production from CFs. GMCSF then drives differentiation of heartinfiltrating MO/Ms toward a proinflammatory phenotype that in turn promotes DCMi.
In conclusion, our study demonstrates that the IL17A-IL 17RA axis is critical in the development of DCMi, a fatal inflammatory heart disease. IL17A induces chemokine pro duction by CFs, resulting in an infiltrate rich in neutrophils and Ly6C hi MO/Ms in the heart. Furthermore, IL17A directs monocytic infiltrates into an even more inflammatory pheno type by inducing GMCSF production from CFs. This novel pathway provides new potential markers to identify myocarditis patients with a high risk of developing DCMI. This pathway further suggests new targets for the prevention of DCMi. In addition, other groups have shown that IL17A is critical in in flammatory diseases including myocardial ischemia/reperfu sion injury (Liao et al., 2012) , pulmonary fibrosis (Wilson et al., 2010) , and liver cirrhosis (Kono et al., 2011) . The pathway involving IL17A, fibroblasts, GMCSF, and MO/Ms may therefore play a key role in many other diseases.
MATERIALS AND METHODS
Mice. Il17ra / founder mice backcrossed eight generations from C57BL/6 to BALB/c background were provided by Amgen Inc. and J. Kolls (Chil dren's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, PA; Yu et al., 2008) . WT BALB/cJ and CBy.PL(B6)Thy1a/ScrJ (Thy1.1) founder mice were purchased from The Jackson Laboratory. Il17ra / mice were crossed to Thy1.1 mice and bred to homozygosity at both loci for the generation of BM chimeras. All mice were maintained in the Johns Hopkins University School of Medicine specific pathogenfree vivarium. Agematched WT, Thy1.1, and Il17ra / mice bred separately in the Johns Hopkins vivarium were used for experiments involving multiple gene backgrounds. For experiments conducted exclusively on WT back ground, WT BALB/cJ (000651) mice (The Jackson Laboratory) were housed in the Johns Hopkins vivarium for a week before immunization. Experi ments were conducted on 6-10wkold male mice, and in compliance with the Animal Welfare Act and the principles set forth in the Guide for the Care and Use of Laboratory Animals. All methods and protocols are approved by the Animal Care and Use Committee of The Johns Hopkins University.
Induction of EAM and DCMi. We used the myocarditogenic peptide MyHC 614629 (AcSLKLMATLFSTYASAD) commercially synthesized by fMOC chemistry and purified to a minimum of 90% by HPLC (Genscript). On days 0 and 7, mice received axillary s.c. immunizations of 100 µg MyHC 614629 peptide emulsified in CFA (SigmaAldrich) supplemented to 5 mg/ml of heatkilled M. tb strain H37Ra (Difco). On day 0, mice also received 500 ng pertussis toxin i.p. (List Biologicals).
Assessment of EAM and DCMi histopathology. Mice were evaluated for the development of EAM and DCMi on days 21 and 63, respectively. Heart tissues were fixed in SafeFix solution (Thermo Fisher Scientific). Tissues were embedded longitudinally, and 5µm serial sections were cut and stained with H&E or Masson's trichrome blue (HistoServ). Myocarditis severity was evaluated by H&E staining of myocardium area infiltrated with hematopoietic cells, according to the following scoring system: grade 0, no inflammation; grade 1, <10% of the heart section is involved; grade 2, 10-25%; grade 3, 25-50%; grade 4, 50-75%; grade 5, >75%. Grading was performed by grading five sections per heart by two independent, blinded investigators and averaged. Cardiac fibrosis was evaluated by measuring the area of blue staining of fibrosis as a proportion of heart cross section. from cardiac damage. In addition, IL17A signaling to cardiac resident cells was essential for the IL17A-driven recruitment of neutrophils and Ly6C hi monocytes to the inflamed heart.
A recent study found that IL17A was able to induce apoptosis in neonatal CMs in vitro (Liao et al., 2012) . The authors suggested that this effect contributed to CM death during myocardial infarction in adult mice. Other investiga tors reported that IL17A induced collagen production in neonatal CFs . However, neonatal cells have unique properties that are not retained in adult cells and are not necessarily the appropriate model to study adult diseases. We observed that IL17A neither induced apoptosis nor acti vated the NFB pathway in primary adult CMs in vitro, in dicating that CMs are not likely to be the primary target of IL17A in adults. In addition, IL17A did not directly stimu late collagen production in adult CFs.
In contrast, adult CFs respond to IL17A by producing high levels of chemokines and cytokines known to facilitate myeloid cell recruitment and instruct their in situ differentia tion toward an inflammatory phenotype. CFs isolated from Il17ra / mice during EAM expressed significantly lower levels of proinflammatory cytokines and chemokines. Impor tantly, although it was reported that ECs react to IL17A stimulation, they produced a minimal amount of cytokines and chemokines compared with CFs; hence, ECs do not ap pear to be the primary target of IL17A in our model of EAM and DCMi. Thus, our study highlights the central, decisive role that nonimmune cells like fibroblasts can play in immuno logical processes. CFs served as a critical mediator between adaptive and innate immune cells and actively participated in the augmentation of immune response. In response to IL17A stimulation from adaptive T cells, CFs produce gran ulocytic and monocytic chemokines to recruit innate effector cells and aggravate the immune response. CFs also secrete cytokines, in this case GMCSF, to direct these recruited MO/M effectors to a more proinflammatory phenotype, which further intensifies inflammation. Moreover, this me diator role played by CFs proved crucial in DCMi, as defi ciency of IL17A/IL17RA signaling in nonhematopoietic cells was sufficient to protect mice from cardiac damage.
Our studies also revealed that the main mediator of local communications between CFs and MO/Ms was CF derived GMCSF. GMCSF is known to elicit the expansion and differentiation of progenitors of the myeloid lineages; GMCSF also supports the survival and activation of effector functions of myeloid cells (Papatriantafyllou, 2011) . In isch emic heart disease, although associated with poor prognosis (Maekawa et al., 2004) , GMCSF has been studied largely for its role outside of its immunological functions. These mecha nisms mostly involve angiogenesis or the mobilization of hematopoietic stem cell-like cells (Zbinden et al., 2005) . There have also been attempts to study the role of GMCSF in myocarditis: Blyszczuk et al. (2013) argued that GMCSF does not affect dendritic cell functions during the effector phase of EAM; however, they neglected to address the effects of GMCSF on MO/Ms and their impact on cardiac damage. and hearts were perfused with calciumfree perfusion buffer, and digested by type II collagenase (Worthington Biochemical Corporation). CMs were sepa rated from resulting suspensions by their rapid spontaneous precipitation. Iso lated CMs were cultured in mouse laminincoated plates or chamber slides and used for experiments after 24 h. CFs and other cell populations remain in super natant and were seeded on uncoated plates in DMEM with 4.5 g/liter glucose, 2 mM lglutamine, 1 mM sodium pyruvate, 25 mM Hepes, 100 U/ml penicil lin G, 100 µg/ml streptomycin, 250 ng/ml amphotericin B, and 20% FBS. Nonadherent cells were washed off after 45 min. Infiltrating hematopoietic cells die off in high FBS media due to cytokine exhaustion, resulting in CF culture.
Western blot. Cells were collected in RIPA buffer (SigmaAldrich), and total protein was quantified by BCA assay (Thermo Fisher Scientific). 20 µg of sample were separated with 10% SDSPAGE with MiniProtean precast gels (BioRad Laboratories). After transfer to PVDF membrane (BioRad Laboratories), IB was blotted with mAb clone L35A5 (Cell Signaling Technology), and actin was blotted with mAb clone 13E5 (Cell Signaling Technology). HRPconjugated secondary antibodies (Jackson Immuno Research Laboratories, Inc.) and Amersham ECL Prime detection system (GE Healthcare) was used to visualize the bands.
BM-derived macrophage. BM cells from femur and tibia were isolated from adult WT BALB/cJ mice and cultured in DMEM with 4.5 g/liter glucose, 2 mM lglutamine, 1 mM sodium pyruvate, 25 mM Hepes, 100 U/ml penicil lin G, 100 µg/ml streptomycin, 55 µM 2mercaptoethanol, and 10% FBS sup plemented with 10 ng/ml recombinant MCSF (R&D Systems) for 8 d.
Immunofluorescence microscopy. CFs and BMderived macrophages were grown on chamber slides (Thermo Fisher Scientific). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X100 (SigmaAldrich). After blocking with donkey serum, cells were incubated with anti-SMA (Abcam) and anti-mouse CD11b (eBioscience clone M1/70) antibodies. FITCconjugated donkey anti-rabbit and Texas red-conjugated donkey anti-rat secondary antibodies with minimal cross reactivity (Jackson ImmunoResearch Laboratories) were then used. Cells were counterstained by DAPI. Images were acquired by an Eclipse 90i microscope (Nikon) at 20× magnification and Volocity image analysis software (PerkinElmer).
ELISA.
Quantitative sandwich ELISA for cell culture supernatants were determined by colorimetric ELISA kits according to the manufacturers' rec ommended protocols (R&D Systems).
Statistics.
Normally distributed data were analyzed by twotailed Student's t test (up to two groups), oneway ANOVA followed by Tukey's posttest, or twoway ANOVA (multiple factor analysis) followed by Tukey's post test. EAM severity scores were analyzed by MannWhitney U test. Values of P < 0.05 were considered statistically significant.
